Review article
Clostridium Difficile Associated Diseases – an Emerging Problem
Dtsch Arztebl 2007; 104(22): A-1588
; ; ; ;
For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.
| 1. | Kuijper EJ, van den Berg RJ, Debast S et al.: Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 2006; 12: 827–30. MEDLINE |
| 2. | Kyne L, Hamel MB, Polavaram R, Kelly CP: health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34: 346–53. MEDLINE |
| 3. | Robert-Koch-Institut, Epidemiologisches Bulletin 36/2006, www.rki.de |
| 4. | Tedesco FJ, Barton RW, Alpers DH: Clindamycin-associated colitis. A prospective study. Ann Intern Med 1974; 81: 429–33. MEDLINE |
| 5. | Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL: Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136: 701–5. MEDLINE |
| 6. | Sebaihia M, Wren BW, Mullany P et al.: The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 2006; 38: 779–86. MEDLINE |
| 7. | Bartlett JG: Narrative Review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145: 758–64. MEDLINE |
| 8. | Cloud J, Kelly CP: Update on Clostridium difficile-associated disease. Curr Opin Gastroenterol 2007; 23: 4–9. MEDLINE |
| 9. | McDonald LC, Killgore GE, Thompson A et al.: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353: 2433–41. MEDLINE |
| 10. | McFarland LV, Mulligan ME, Kwok RY, Stamm WE: Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204–10. MEDLINE |
| 11. | Schroder O, Gerhard R, Stein J: Antibiotika-assoziierte Diarrhö. Z Gastroenterol 2006; 44: 193–204. MEDLINE |
| 12. | McDonald LC, Owings M, Jernigan DB: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006; 12: 409–15. MEDLINE |
| 13. | Kuijper EJ, Coignard B, Tull P: The ESCMID Study Group for Clostridium Difficile (ESGCD): emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 (Suppl 6): 2–18. MEDLINE |
| 14. | Centers for Disease Control and Prevention (CDC): Severe Clostridium difficile-associated disease in populations previously at low risk – four states. MMWR Morb Mortal Wkly Rep 2005; 54: 1201–5. MEDLINE |
| 15. | Heimesaat MM, Granzow K, Leidinger H, Liesenfeld O: Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea. Infection 2005; 33: 340–4. MEDLINE |
| 16. | Ash L, Baker ME, O'Malley CM Jr et al.: Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. American Journal of Radiology 2006; 186: 1393–400. MEDLINE |
| 17. | Bricker E, Garg R, Nelson R et al.: Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev(1) 2005; CD004610. MEDLINE |
| 18. | Fekety R: Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997; 92: 739–50. MEDLINE |
| 19. | Fernandez A, Anand G, Friedenberg F: Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004; 38: 414–8. MEDLINE |
| 20. | Pepin J, Valiquette L, Alary ME et al.: Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Cmaj 2004; 171: 466–72. MEDLINE |
| 21. | Suarawicz CM: Treatment of recurrent Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol & Hepatol 2004; 1: 32–8. MEDLINE |
| 22. | McFarland LV, Surawicz CM, Greenberg RN et al.: A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. Jama 1994; 271: 1913–8. MEDLINE |
| 23. | Babcock GJMR, Coccia JA, Esshaki DJ et al.: Human monoclonal antibody against toxin A protects hamsters from Clostridium difficile disease. Paper presented at the 42nd Annual Meeting of the Infectious Disease Society of America. Boston 2004. |
| 24. | Louie TJ, Peppe J, Watt CK et al.: Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis 2006; 43: 411–20. MEDLINE |
| 25. | Koss K, Clark MA, Sanders DS et al.: The outcome of surgery in fulminant Clostridium difficile colitis. Clorectal Dis 2006; 8: 149–54. MEDLINE |
| 26. | Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr.: Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16: 459–77. MEDLINE |
